Metformin Use in Adolescents

April 2013
American Family Physician;4/15/2013, Vol. 87 Issue 8, p1
Academic Journal
The article discusses the study on the effectiveness of metformin therapy in reducing the development of diabetes mellitus in obese adolescents. It states that metformin reduces body mass index (BMI) for up to six months in obese adolescents. It cites that patients who received metformin had reduced prevalence of steatosis and improved the fatty liver severity scores. It also mentions that patients with moderate risk of diabetes development are recommended to use metformin.


Related Articles

  • Lack of Sleep Linked to Obesity.  // USA Today Magazine;Oct2012, Vol. 141 Issue 2809, p14 

    The article discusses a study by the University of Chicago in Illinois which revealed that inadequate sleep is linked to increased risk of obesity and the association between lack of sleep and higher body mass index (BMI) is stronger in children and adolescents.

  • AMPK as Target for Intervention in Childhood and Adolescent Obesity. Rojas, Joselyn; Arraiz, Nailet; Aguirre, Miguel; Velasco, Manuel; Bermúdez, Valmore // Journal of Obesity;2011, Vol. 2011, Special section p1 

    Childhood obesity is a major worldwide health problem. Intervention programs to ameliorate the rate of obesity have been designed and implemented; yet the epidemic has no end near in sight. AMP-activated protein kinase (AMPK) has become one of the most important key elements in energy control,...

  • Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience. Anichini, Roberto; Cosimi, Sabrina; Di Carlo, Alberto; Orsini, Paola; De Bellis, Alessandra; Seghieri, Giuseppe; Franconi, Flavia; Baccetti, Fabio // Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy;Apr2013, Vol. 6, p123 

    Purpose: To investigate whether gender affects therapeutic response by exenatide twice a day (BID) in type 2 diabetes by using a database concerning patients monitored by five outpatient clinics in Tuscany, Italy. Patients and methods: We considered a cohort of 315 (154 male/161 female) patients...

  • PCOS Patients with Lower BMI may Respond Better to Treatment.  // Fertility Weekly;11/7/2011, p5 

    The article reports on the statement of researchers in New Zealand that lower body mass index (BMI) is important to better respond to metformin treatment in women with anovulatory polycystic ovary syndrome (PCOS). Researcher Neil P. Johnson and colleagues write that BMI had a greater influence...

  • Lipid profile of patients having non-alcoholic fatty liver disease as per ultrasound findings in north Indian population: A retrospective observational study. Sen, Abhijit; Kumar, Jitendra; Misra, Rajendra Prasad; Uddin, Muneer; Shukla, P. C. // Journal of Medical & Allied Sciences;8/31/2013, Vol. 3 Issue 2, p59 

    A hospital-based cross-sectional study was conducted to assess the lipid profile and body mass index (BMI) of the patients suffer-ing from non-alcoholic fatty liver disease (NAFLD) in north Indian population. A total of 385 ultrasound proven NAFLD patients were included in the study. The...

  • Grape Seed Proanthocyanidin Rescues Rats from Steatosis: A Comparative and Combination Study with Metformin. Yogalakshmi, Baskaran; Sreeja, S.; Geetha, Rajagopalan; Radika, Mutlur Krishnamoorthy; Anuradha, Carani Venkatraman // Journal of Lipids;2013, p1 

    Nonalcoholic fatty liver disease (NAFLD), a premorbid condition, lacks proper management owing to multitude of abnormalities. In this study, we compared the effects of a potent antioxidant, grape seed proanthocyanidins (GSP), and an insulin sensitizer, metformin (MET), in high-fat-fructose-diet-...

  • BMI values and other anthropometric and functional measurements as predictors of obesity in a selected group of adolescents. Turconi, G.; Guarcello, M.; Maccarini, L.; Bazzano, R.; Zaccardo, A.; Roggi, C. // European Journal of Nutrition;Apr2006, Vol. 45 Issue 3, p136 

    Background Obesity is well known to be a problem all over the world: WHO data report that one billion subjects are overweight and 300 million are obese. Epidemiological data (IOTF) show that prevalence rates are increasing not only in industrialized countries, but also in developing countries,...

  • Effects of Sibutramine Treatment in Obese Adolescents. Berkowitz, Robert I.; Fujioka, Ken; Daniels, Stephen R.; Hoppin, Alison G.; Owen, Stanford; Perry, Arlette C.; Sothern, Melinda S.; Renz, Cheryl L.; Pirner, Mark A.; Walch, Julia K.; Jasinsky, Olga; Hewkin, Ann C.; Blakesley, Vicky A. // Annals of Internal Medicine;7/18/2006, Vol. 145 Issue 2, p81 

    Background: Increased prevalence of adolescent obesity requires effective treatment options beyond behavior therapy. Objective: To see whether sibutramine reduced weight more than placebo in obese adolescents who were receiving a behavior therapy program. Design: 12-month, 3:1 randomized,...

  • The Relationship between Overweight in Adolescence and Premature Death in Women. van Dam, Rob M.; Willett, Walter C.; Manson, Joann E.; Hu, Frank B. // Annals of Internal Medicine;7/18/2006, Vol. 145 Issue 2, p91 

    Background: The impact of adiposity in adolescence on death during adulthood is uncertain. Objective: To examine the relation between adiposity in adolescence and premature death in women. Design: Prospective cohort study. Setting: United States. Participants: 102 400 women from the Nurses'...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics